间歇性θ爆发刺激治疗青少年抑郁症急性期的临床疗效:双盲随机对照试验研究方案
本研究为单中心、随机、双盲、假刺激对照临床试验,计划招募约76名14-18岁抑郁症急性期青少年,随机分为iTBS治疗组(n=38)与假对照组(n=38)。每名受试者接受10天共10次iTBS,刺激强度为活动阈值的80%,每次1800脉冲,靶点为左侧背外侧前额叶皮层。评估在基线、治疗结束时及治疗后第2、4周随访进行,旨在探索iTBS在青少年抑郁症急性期的临床疗效与安全性。
要点
- iTBS每日一次连续10天,80%活动阈值,每次1800脉冲,靶点左侧DLPFC。
- 计划招募76名14-18岁抑郁症急性期青少年,随机双盲假刺激对照。
- 评估时点为基线、治疗结束及治疗后第2、4周随访,含临床与神经生理评估。
核心结论
- 本研究旨在探索iTBS对青少年抑郁症急性期的临床疗效,以期缩短治疗疗程并加快临床应答。
研究设计与样本
- 单中心、随机、双盲、假刺激对照临床试验,计划招募约76名14-18岁抑郁症急性期患者。
- 受试者随机分为治疗组(n=38)与假对照组(n=38)。
- 干预为10天内10次iTBS,刺激强度为活动阈值的80%,每次1800脉冲,靶点为左侧背外侧前额叶皮层。
- 评估在基线、治疗结束时及治疗后第2、4周随访进行,安全性通过半结构化访谈和不良事件报告监测。
关键数值与推荐
- iTBS参数:80%活动阈值,每次1800脉冲,每日1次,连续10天,靶点左侧DLPFC。
- 计划样本量:约76例,治疗组38例,假对照组38例。
- 评估时点:基线、治疗结束、治疗后第2周和第4周随访。
临床怎么用
- 若验证有效,iTBS可作为青少年抑郁症急性期10天短程干预方案,补充现有治疗。
- 治疗期间需通过半结构化访谈和不良事件报告监测安全性。
局限性
- 研究方案阶段,尚未报告临床疗效与安全性结果。
- 单中心设计,样本量约76例,可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adolescent depression is a significant health problem, and developing safe and rapid treatments for it is crucial. Intermittent theta burst stimulation (iTBS), a novel form of repetitive transcranial magnetic stimulation (rTMS), enhances synaptic transmission and cortical excitability by simulating cortical rhythms and has demonstrated certain therapeutic effects in adults. Adolescents in the acute phase of depression present with more severe symptoms and are pressed for time, so a short, effective modality like iTBS could be particularly advantageous. However, studies on the effects of iTBS during the acute phase of adolescent depression are still fairly limited. Therefore, this study aims to explore the clinical efficacy of iTBS in adolescents with depression during the acute phase through a viable research design. METHODS: This is a single-center, randomized, double-blind, and sham-stimulation-controlled clinical trial. We plan to recruit approximately 76 adolescent patients with depression aged 14-18 years. Eligible participants will be randomly assigned to the treatment group (n = 38) or the sham control group (n = 38). Each participant will receive 10 sessions of iTBS over 10 days, delivered at 80% of the active threshold, with 1,800 pulses per session. The treatment target will be the left dorsolateral prefrontal cortex. Clinical and neurophysiological assessments will be conducted at baseline, at the end of treatment, and during follow-up at weeks 2 and 4 after treatment completion. Safety will be monitored through semi-structured interviews and the reporting of adverse events. DISCUSSION: Conventional rTMS treatment faces logistical challenges due to its standard course requiring daily treatment over 4-6 weeks. This study aims to explore a safe and effective iTBS protocol for adolescent patients with depression to complement existing treatments. By evaluating clinical symptoms and the most sensitive neurophysiological features after treatment, we hope to optimize the iTBS protocol. This study aims to reduce the treatment duration, alleviate the economic burden on families and society, and expedite the clinical response for adolescent patients. TRIAL REGISTRATION: The trial was registered with the Chinese Clinical Trial Registry. REGISTRATION NUMBER: ChiCTR2500101152. Retrospectively registered on 21 April 2025.
引用
- Ye Q, Yang Y, Cai W, et al. Clinical efficacy of intermittent theta burst stimulation in the acute phase of adolescent depression: study protocol of a double-blind, randomized controlled trial. Trials. 2026. PMID: 41975503. doi:10.1186/s13063-026-09705-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。